Literature DB >> 30555101

Infective Endocarditis in Cancer Patients - Causative Organisms, Predisposing Procedures, and Prognosis Differ From Infective Endocarditis in Non-Cancer Patients.

Kyu Kim1, Darae Kim1, Sang-Eun Lee1, In Jeong Cho1, Chi Young Shim1, Geu-Ru Hong1, Jong-Won Ha1.   

Abstract

BACKGROUND: Infective endocarditis (IE) in cancer patients is increasing, but because little is known about it in these patients, we analyzed patient characteristics and outcomes and compared these factors in IE patients with and without cancer. Methods and 
Results: This retrospective cohort study included 170 patients with IE newly diagnosed between January 2011 and December 2015. Among 170 patients, 30 (17.6%) had active cancer. The median age of IE patients with cancer was higher than that of non-cancer patients. Nosocomial IE was more common in cancer patients. Non-dental procedures, such as intravenous catheter insertion and invasive endoscopic or genitourinary procedures, were more frequently performed before IE developed in cancer patients. Staphylococcus was the most common pathogen in cancer patients, whereas Streptococcus was the most common in non-cancer patients. In-hospital mortality was significantly higher in cancer patients with IE (34.4% vs. 12.4%, P<0.001). IE was an important reason for discontinuing antitumor therapy and withholding additional aggressive treatment in nearly all deceased cancer patients.
CONCLUSIONS: IE is common in cancer patients and is associated with poorer outcomes. Patients with IE and cancer have different clinical characteristics. Additional studies regarding antibiotic prophylaxis before non-dental invasive procedures in cancer patients are needed, as cancer patients are not considered to be at higher risk of IE.

Entities:  

Keywords:  Antibiotic prophylaxis; Cancer; Endocarditis

Mesh:

Year:  2018        PMID: 30555101     DOI: 10.1253/circj.CJ-18-0609

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

Review 1.  Overview and Comparison of Infectious Endocarditis and Non-infectious Endocarditis: A Review of 814 Autoptic Cases.

Authors:  Rossana Bussani; Fabio DE-Giorgio; Giuliano Pesel; Lorenzo Zandonà; Gianfranco Sinagra; Simone Grassi; Alfonso Baldi; Antonio Abbate; Furio Silvestri
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

Review 2.  Malignancy and Endocarditis: Divulging Into the Intertwined Association.

Authors:  Lakshmi Sree Pugalenthi; Mahlika Ahmad; Sanjana Reddy; Zineb Barkhane; Jalal Elmadi; Lakshmi Satish Kumar
Journal:  Cureus       Date:  2022-04-12

Review 3.  Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer.

Authors:  Juan C Lopez-Mattei; Eric H Yang; Maros Ferencik; Lauren A Baldassarre; Susan Dent; Matthew J Budoff
Journal:  JACC CardioOncol       Date:  2021-12-21

4.  Impact of underlying malignancy on emergency department utilization and outcomes.

Authors:  Alexander S Qian; Edmund M Qiao; Vinit Nalawade; Rohith S Voora; Nikhil V Kotha; Christian Dameff; Christopher J Coyne; James D Murphy
Journal:  Cancer Med       Date:  2021-11-24       Impact factor: 4.452

Review 5.  Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?

Authors:  Sabina Mędrek; Sebastian Szmit
Journal:  Front Cardiovasc Med       Date:  2022-09-23

6.  Characteristics of infective endocarditis in a cancer population.

Authors:  Cullen Grable; Syed W Yusuf; Juhee Song; George M Viola; Owais Ulhaq; Jose Banchs; Corey T Jensen; Harsh Goel; Saamir A Hassan
Journal:  Open Heart       Date:  2021-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.